Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BIIX 1 XX in Healthy Male Volunteers
NCT02198287Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 1999
- Primary completion
- Apr 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in asthma comparing BIIX 1 XX with Placebo (2 arms). Primary endpoints: Number of patients with adverse events up to 22 days, Number of patients with clinically relevant changes in vital parameters (Blood pressure, Pulse rate) and 4 more. Started Jan 1999; status: completed.
02
Drugs
olodaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02198287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02198287.